Insights & Resources

Research, Data & Strategic Intelligence

In-depth analysis for clinicians, attorneys, and patients. From biomarker science to practical recovery guides.

Featured

Essential Reading

Legal Strategy18 min read

Biomarker Evidence in TBI Litigation: A Guide for Personal Injury Attorneys

How blood-based biomarkers are transforming the evidentiary standard in traumatic brain injury cases. Includes settlement impact data, admissibility considerations, and defense counter-strategies.

Request Access

Biomarker Science22 min read

GFAP and NfL in Clinical Practice: Detection, Monitoring, and Prognostic Value

A clinical reference covering the two most validated blood biomarkers for TBI. Mechanism of action, diagnostic windows, interpretation thresholds, and longitudinal monitoring protocols.

Request Access

Full Library

All Resources

Legal Strategy18 min read

Biomarker Evidence in TBI Litigation: A Guide for Personal Injury Attorneys

How blood-based biomarkers are transforming the evidentiary standard in traumatic brain injury cases. Includes settlement impact data, admissibility considerations, and defense counter-strategies.

FDA-cleared biomarker evidence and Daubert/Robinson admissibility

Settlement value analysis: baseline vs. biomarker-supported cases

Counter-strategy framework for common defense arguments

Chain-of-custody and documentation best practices

Request Access

Biomarker Science22 min read

GFAP and NfL in Clinical Practice: Detection, Monitoring, and Prognostic Value

A clinical reference covering the two most validated blood biomarkers for TBI. Mechanism of action, diagnostic windows, interpretation thresholds, and longitudinal monitoring protocols.

GFAP peak detection windows and half-life data

NfL as a chronic injury trajectory marker

Interpretation thresholds for clinical decision-making

Serial measurement protocols for recovery monitoring

Request Access

Sports Medicine15 min read

Objective Concussion Protocols: Biomarker-Based Return-to-Play Governance

A framework for athletic organizations to implement biomarker-based concussion management. Covers baseline testing, incident response, threshold-based decision-making, and liability reduction.

Baseline, incident, and follow-up monitoring model

Green/Yellow/Red threshold-based action protocols

NFL settlement context and liability landscape ($1.18B+)

Longitudinal tracking and cumulative exposure analytics

Request Access

Military & Defense20 min read

Blast Exposure and Military TBI: The Case for Standardized Biomarker Screening

Addressing the measurement gap in military neurotrauma. How blood-based biomarkers can support blast exposure screening, return-to-duty decisions, veteran claims, and population-level policy.

400,000+ military TBI cases since 2000

Subclinical blast injury detection with biomarkers

Pre/post-deployment screening protocols

Veteran disability claims evidence framework

Request Access

Market Analysis12 min read

The TBI Diagnostics Market: From Subjective Assessment to Molecular Evidence

Market analysis covering the shift from imaging-based TBI evaluation to blood-based biomarker diagnostics. Growth projections, regulatory catalysts, and the emerging competitive landscape.

$1.13B market size (2024) with 18.5% CAGR through 2034

FDA clearance timeline and regulatory momentum

Insurance, legal, and clinical adoption drivers

Competitive landscape and technology differentiation

Request Access

Patient Guide8 min read

Understanding Brain Injury Testing: A Guide for Patients and Families

A clear, straightforward explanation of what blood-based brain injury testing is, how it works, and what your results mean — written in plain language for patients and their loved ones.

What biomarkers are and why they matter for brain injury

Step-by-step guide to the testing process

How to read and understand your results

Questions to ask your doctor or care team

Request Access

Recovery Guide10 min read

Concussion Recovery: What to Expect and How to Track Progress

A patient-friendly guide to concussion recovery timelines, warning signs, and how biomarker testing can help monitor healing and inform treatment decisions.

Typical concussion recovery timelines

Red flags that indicate you should seek further care

How biomarker tracking supports recovery monitoring

Tips for managing symptoms during recovery

Request Access

Get Access

Request Your Resource

Submit your information below and we will send you access to our resource library. Select the topic most relevant to your work.

Resource Access

Complete the form to receive your selected resource.

Coming Soon

Additional Resources in Development

Case Study Series

Detailed case outcomes showing how biomarker evidence impacted settlement values, jury decisions, and clinical interventions.

Clinical Protocols Handbook

Step-by-step clinical integration guides for hospitals, urgent care, and specialty practices implementing biomarker testing.

Policy Briefs

Analysis of FDA developments, state-level legislation, and institutional adoption of biomarker-based TBI protocols.

Research, Data & Strategic Intelligence

Essential Reading

Biomarker Evidence in TBI Litigation: A Guide for Personal Injury Attorneys

GFAP and NfL in Clinical Practice: Detection, Monitoring, and Prognostic Value

All Resources

Biomarker Evidence in TBI Litigation: A Guide for Personal Injury Attorneys

GFAP and NfL in Clinical Practice: Detection, Monitoring, and Prognostic Value

Objective Concussion Protocols: Biomarker-Based Return-to-Play Governance

Blast Exposure and Military TBI: The Case for Standardized Biomarker Screening

The TBI Diagnostics Market: From Subjective Assessment to Molecular Evidence

Understanding Brain Injury Testing: A Guide for Patients and Families

Concussion Recovery: What to Expect and How to Track Progress

Request Your Resource

Resource Access

Additional Resources in Development

Case Study Series

Clinical Protocols Handbook

Policy Briefs

Stay Informed